Revenue from direct MagnetOs product sales rose 149% in the first nine months of 2024, to CHF 50.6 million from CHF 20.4 million, compared to the same period in 2023. Total revenue from medical ...

With an FDA decision looming over its first foray into the acute pain space, Vertex Pharmaceuticals has commissioned a pair of surveys to take stock of that space. The resulting report ...

Kuros reports 149% increase in direct MagnetOs sales and exceeds cash flow breakeven in the first nine months of 2024 10-Oct-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art.

Vertex (VERX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates ...

Please verify your email address. Wolverine has heroically defeated Magneto numerous times even though his skeleton is made of metal. Psylocke's betrayal led to her killing Magneto with a psychic ...

Vertex Pharmaceuticals (VRTX) closed at $465.08 in the latest trading session, marking a +0.48% move from the prior day. This move outpaced the S&P 500's daily gain of 0.42%. Meanwhile, the Dow ...